Related Experiment Video
Updated: Jan 7, 2026

11:17
Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin
Published on: March 10, 2021
6.7K
Empty MHC Class I Protein Production.
Ankur Saikia1, Yelyzaveta Makedon1, Bianka Nagy1
1Constructor University, Bremen, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|January 1, 2026
Summary
This study details a protocol for producing and refolding peptide-empty MHC class I proteins. This method yields functional proteins for biochemical research.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- MHC class I proteins are crucial for immune response.
- Recombinant production of functional MHC class I proteins is challenging.
- Disulfide-stabilized, peptide-empty forms are valuable research tools.
Purpose of the Study:
- To provide a detailed protocol for recombinant production of MHC class I proteins.
- To describe in vitro refolding of disulfide-stabilized, peptide-empty MHC class I molecules.
- To enable the generation of functional MHC class I proteins for biochemical and biophysical studies.
Main Methods:
- Expression of MHC class I heavy and light chains (β2m) in E. coli as inclusion bodies.
- Purification of expressed proteins and inclusion bodies.
- In vitro refolding of disulfide-stabilized MHC class I molecules using a dilution method with dipeptides.
Main Results:
- Successful recombinant production of MHC class I heavy and light chains.
- Efficient purification of inclusion bodies containing the target proteins.
- Achieved in vitro refolding of disulfide-stabilized, peptide-empty MHC class I proteins using a dilution method.
Conclusions:
- The protocol effectively produces correctly folded, functional, peptide-empty MHC class I proteins.
- This method is suitable for generating proteins required for various biochemical and biophysical assays.
- The developed protocol facilitates research in immunology and protein structure-function relationships.
Keywords:
Disulfide-mediated stabilizationE. coli expressionInclusion bodiesMHC Class IProtein refoldingSize exclusion chromatographyMore Related Videos
Related Concept Videos
Antigen Processing Pathways
2.0K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
2.0K
Antigens Involved in Adaptive Immunity
1.2K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.2K
T Cell Activation and Clonal Selection
14.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.5K
Hybridoma Technology
17.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.1K
Cell-mediated Immune Responses
83.3K
Overview
83.3K
B Cell Activation and Differentiation
15.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.8K

